關於我們 About Us
Company Introduction
盟森管理顧問股份有限公司秉持「以信為盟，森羅共創未來」的核心價值，象徵著我們秉持誠信原則，與合作夥伴緊密結盟，共同創造卓越成就。我們堅持進可攻、退可守的經營策略，不僅追求事業成功，更致力於為客戶與夥伴帶來共好，實現長遠且穩固的合作關係。我們的公司精神體現在「結盟、誠信、共好」的價值觀中。主要業務涵蓋生物科技領域，包括機能性食品原料的開發、保健品與保養品的行銷推廣及銷售，以及生技醫藥商品的商業化輔導服務。此外，我們也提供生物科技企業的募資、併購及技術授權的橋接與輔導，致力於幫助企業在市場上取得成功，推動產業持續成長與創新。
MS BIO-Consulting Co., Ltd. upholds the core value of “Trust as Our Alliance, Creating the Future Together.” This reflects our commitment to integrity as we build strong alliances with our partners to achieve remarkable success together. We adhere to a strategy that balances both proactive advancement and prudent defense, aiming not only for business success but also for creating mutual benefits for our clients and partners, fostering long-term and stable relationships. Our company spirit is embodied in the values of "Alliance, Integrity, and Mutual Benefit."
Our primary focus is in the biotechnology sector, covering the development of functional food ingredients, the marketing and sales of health and skincare products, and the commercialization guidance for biotech pharmaceutical products. Additionally, we provide support in fundraising, mergers and acquisitions, and technology licensing for biotechnology companies, helping them succeed in the market and driving the continuous growth and innovation of the industry.
我們專注於商務開發與財務服務，提供全面且專業的支持，助力客戶在市場中取得成功。在商務開發方面，我們涵蓋以下服務：
1.授權合作 (Out-Licensing)：協助 505(b)(1) 和 505(b)(2) 新藥的授權合作，促進產品與市場的有效對接。
2.產品市場進入：幫助仿製藥、保健品及醫療器材進入美國及東南亞市場，為客戶拓展新商機。
3.CMO 引薦：為客戶對接美國及東南亞的代工生產服務，包括醫療器材和保健品的代工製造商 (CMOs)。
在財務服務方面，我們提供：
1.募資支持：專注於協助新藥及醫療科技公司尋求募資資源。
2.併購服務 (M&A)：提供創新型初創企業及成熟企業的戰略併購規劃，助力企業實現成長與整合目標。
We specialize in business development and financial services, offering comprehensive and professional support to help our clients achieve success in the market. Our key offerings include:
Business Development:
1.Out-Licensing: Facilitating out-licensing opportunities for 505(b)(1) and 505(b)(2) new drugs to ensure effective market alignment.
2.Product Market Entry: Supporting the market entry of generics, supplements, and medical devices in the US and Southeast Asia, helping clients expand their business opportunities.
3.CMO Introduction: Connecting clients with contract manufacturing organizations (CMOs) in the US and Southeast Asia, covering device manufacturing and supplement production.
Financial Services:
1.Fundraising: Assisting new drug companies and medtech firms in securing funding resources to fuel growth and innovation.
2.Mergers and Acquisitions (M&A): Providing strategic M&A solutions for startups and mature businesses, enabling growth, integration, and value creation.
我們的團隊
Meet the Team
藥品產業經驗
團隊成員曾任職於新藥公司與仿製藥公司，擁有豐富的實務經驗。在新藥公司擔任商務開發（BD）要職，主導國際授權談判並成功完成對外授權。同時，協助藥品開發流程中關鍵的代工生產（CMO）串接，並推動產品從開發到進入美國市場的完整商業化過程。
醫療器材產業經驗
團隊成員曾在大型國際醫療器材公司擔任重要職位，專注於串聯國際間的產品開發、生產製造與策略合作。透過多方資源整合，推動醫療器材的國際化佈局，實現產品在全球市場的價值最大化。
保健品產業經驗
在保健品領域，團隊成員曾任職於國際大型保健品公司，深入參與從產品開發到生產及銷售的全過程。憑藉對產業供應鏈的全面理解，促進保健品產品的市場化與商業成功。
創業投資與策略性投資經驗
團隊成員曾任職於國際知名創投公司及世界級大型集團的投資部門，累積超過30件國內外藥品、醫療器材及保健品公司的投資案例。此外，在併購方面，成功主導包括買方與賣方的整合案，完成藥品與醫療器材公司的整併，為企業提供持續增值的策略性布局。
Pharmaceutical Industry Experience
Our team members have extensive hands-on experience in the pharmaceutical industry, having worked for both innovative drug companies and generic drug companies. In new drug companies, the team member led key business development (BD) initiatives, successfully negotiating and completing international licensing deals. They facilitated critical connections with contract manufacturing organizations (CMOs) in the drug development process, driving the full commercialization of products and enabling their entry into the U.S. market.
Medical Device Industry Experience
Our team members have held significant positions at large international medical device companies, focusing on connecting global product development, manufacturing, and strategic partnerships. Through the integration of diverse resources, they successfully advanced the internationalization of medical devices, maximizing their value in global markets.
Supplement Industry Experience
In the supplement sector, our team members have worked for major international health product companies, deeply involved in the entire process from product development to manufacturing and sales. Leveraging a comprehensive understanding of the industry's supply chain, they effectively facilitated the marketization and commercial success of health product offerings.
Venture Capital and Strategic Investment Experience
Our team members have held roles at internationally renowned venture capital firms and the investment divisions of world-class conglomerates, completing over 30 investment cases in pharmaceutical, medical device, and supplement companies worldwide. Furthermore, we have successfully led mergers and acquisitions (M&A) on both the buy-side and sell-side, completing integrations of pharmaceutical and medical device companies and providing strategic layouts that deliver sustainable value to businesses.
我們的團隊在生技產業中成功處理了多項案例，以下為部分過去案例：
商務開發：
•授權合作：完成一項眼科二期新藥的對外國際授權合作。
•市場進入：協助一款仿製藥成功進入美國市場
•引薦代工廠（OEM/ODM）：為客戶匹配東南亞地區的植物萃取代工廠（OEM/ODM），優化生產能力與供應鏈效率。
財務服務：
•募資：主導一間再生醫學公司的募資計畫，成功為其創新與成長籌集關鍵資金。
•併購：管理一間生命體徵監測公司的併購案，將其整合至大型集團中，擴展市場版圖並提升營運效益。
Our team has successfully handled various cases in the healthcare and biotech industries, some past successful examples including:
Business Development:
•Out-Licensing: Facilitated the out-licensing of a Phase 2 ophthalmology new drug, connecting it with strategic partners for further development.
•Market Entry: Assisted a PIV generic product in successfully entering the US market, overcoming regulatory and market entry challenges.
•Introducing OEM/ODM: Matched clients which needs plant extractionin suppulment products in Southeast Asia, optimizing production capabilities and supply chain efficiency.
Financial Services:
•Fundraising: Led fundraising efforts for a regenerative medicine company, securing critical capital to support their innovation and growth.
•M&A: Managed the acquisition of a vital sign monitoring company, integrating it into a conglomerate to enhance market presence and operational effectiveness.
PARTNERS
•Japan: A Japanese consultant with over 20 years of M&A advisory experiences at Deutsche Bank, Lazard, and BNP Paribas. Past deals include Japan Airlines’ hotel divestiture and SoftBank’s acquisition of Vodafone.
•US: An American consultant with over 20 years of experiences on M&A and PE. Ex-leadership team at McDermott and a big US device co.
•China: A Chinese financial advisory partner with 20+ years experiences in M&A, restructuring, and fundraising. Past deals include billion-dollar CNY M&A cases in China.
•日本：一位擁有超過20年併購諮詢經驗的日本顧問，曾任職於德意志銀行、Lazard與法國巴黎銀行（BNP Paribas）。參與的過往案例包括日本航空的飯店資產剝離及軟銀收購沃達豐（Vodafone）。
•美國：一位擁有超過20年併購及私募股權（PE）經驗的美國顧問，曾是McDermott和一家大型美國醫療器材公司高層團隊成員。
•中國：一位擁有超過20年併購、重組及募資經驗的中國財務諮詢夥伴。過往案例包括數十億元人民幣的中國併購交易案。